Brown Brothers Harriman & Co’s 1Life Healthcare ONEM Stock Holding History

Brown Brothers Harriman & Co’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,693	Closed	-$179K	–	1348
2022 Q4	$179K	Hold	10,693	–	–	﹤0.01%	486
2022 Q3	$183K	Sell	10,693 -96,235	-90%	-$1.51M	﹤0.01%	483
2022 Q2	$838K	Hold	106,928	–	–	0.01%	243
2022 Q1	$1.19M	Hold	106,928	–	–	0.01%	222
2021 Q4	$1.88K	Buy	+106,928	New	+$2.07M	0.01%	178

Brown Brothers Harriman & Co's ONEM Position: Q1 2023 in Review

Brown Brothers Harriman & Co sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 10,693 shares — an estimated $179K sold.

Brown Brothers Harriman & Co first reported a position in ONEM in Q4 2021 and held it in 5 quarters. The position peaked at $1.19M in Q1 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

Brown Brothers Harriman & Co reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
Brown Brothers Harriman & Co sold 10,693 1Life Healthcare shares in Q1 2023, an estimated $179K.
Brown Brothers Harriman & Co first reported a position in 1Life Healthcare in Q4 2021 and held it in 5 quarters.
Brown Brothers Harriman & Co's 1Life Healthcare position peaked at $1.19M in Q1 2022.
0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2023, filed 11 May 2023.